首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Sulindac/tamoxifenLack of efficacy: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2022年
/ 1913卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-022-18547-1
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:397 / 397
相关论文
共 50 条
[31]
RECTAL-CANCER AFTER PROLONGED SULINDAC CHEMOPREVENTION - A CASE-REPORT
LYNCH, HT
论文数:
0
引用数:
0
h-index:
0
机构:
CREIGHTON UNIV,SCH MED,DEPT COLON & RECTAL SURG,OMAHA,NE 68178
LYNCH, HT
THORSON, AG
论文数:
0
引用数:
0
h-index:
0
机构:
CREIGHTON UNIV,SCH MED,DEPT COLON & RECTAL SURG,OMAHA,NE 68178
THORSON, AG
SMYRK, T
论文数:
0
引用数:
0
h-index:
0
机构:
CREIGHTON UNIV,SCH MED,DEPT COLON & RECTAL SURG,OMAHA,NE 68178
SMYRK, T
CANCER,
1995,
75
(04)
: 936
-
938
[32]
SULINDAC HEPATITIS, A NEW CASE
KAMMERER, J
论文数:
0
引用数:
0
h-index:
0
机构:
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
KAMMERER, J
SABARDEIL, S
论文数:
0
引用数:
0
h-index:
0
机构:
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
SABARDEIL, S
RUMEAU, JL
论文数:
0
引用数:
0
h-index:
0
机构:
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
RUMEAU, JL
SALSON, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
SALSON, A
ELHAGE, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
CHU RANGUEIL,SERV ANAT & CYTOL PATHOL,F-31054 TOULOUSE,FRANCE
ELHAGE, A
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE,
1982,
6
(8-9):
: 712
-
713
[33]
STEVENS-JOHNSON SYNDROME DUE TO SULINDAC - A CASE-REPORT AND REVIEW OF THE LITERATURE
MAGUIRE, FW
论文数:
0
引用数:
0
h-index:
0
MAGUIRE, FW
DELAWARE MEDICAL JOURNAL,
1981,
53
(04)
: 193
-
197
[34]
AgomelatineLack of efficacy: case report
Reactions Weekly,
2025,
2047
(1)
: 22
-
22
[35]
MidodrineLack of efficacy: case report
Reactions Weekly,
2024,
2039
(1)
: 335
-
335
[36]
MagnesiumLack of efficacy: case report
Reactions Weekly,
2025,
2048
(1)
: 228
-
228
[37]
TofacitinibLack of efficacy: case report
Reactions Weekly,
2025,
2057
(1)
: 344
-
344
[38]
AlprostadilLack of efficacy: case report
Reactions Weekly,
2025,
2055
(1)
: 23
-
23
[39]
ImmunosuppressantsLack of efficacy: case report
Reactions Weekly,
2022,
1915
(1)
: 236
-
236
[40]
AcetylcysteineLack of efficacy: case report
Reactions Weekly,
2024,
2037
(1)
: 16
-
16
←
1
2
3
4
5
→